Brief by Shorts91 Newsdesk / 01:54pm on 28 Feb 2024,Wednesday Health & Wellness
The Tata Institute in Mumbai has unveiled a groundbreaking cancer treatment tablet priced at just Rs 100. Named 'R+Cu', the tablet claims to prevent cancer recurrence and reduce treatment side effects by 50%. Pending approval from the Food Safety and Standards Authority of India, it could hit the market by June-July. With pro-oxidant properties containing resveratrol and copper, the tablet aims to inhibit cancer cell movement and destroy chromatin particles. This development holds promise for affordable and effective cancer treatment, potentially revolutionizing oncology practices.
